Tadaki Suzuki - Concepedia

Author

Tadaki Suzuki

National Institute of Infectious Diseases ORCID

Also Known As

Hiroaki Mitsuya, Noriyo Nagata, Suzuki, T., T Suzuki, T. Suzuki, T., Suzuki, Tadaki SUZUKI, Tadaki Suzuki, Takayuki Suzuki, Tomohito Suzuki

402

Publications

16.6K

Citations

H-Index

146

Concepts

All Affiliations

National Institute of Infectious Diseases Hokkaido University National Center for Global Health and Medicine Tokyo University of Science The University of Tokyo

About

Tadaki Suzuki is an author at National Institute of Infectious Diseases specializing in medicine, virology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	32	67	6.1K
2	Health Sciences	4	4	106
3	Engineering	3	3	709
4	Public Health	3	3	74
5	Natural Sciences	2	2	109

Tadaki Suzuki

166

Publications

14.5K

Citations

H-Index

Page 1

	Year	Citations
Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells Shutoku Matsuyama, Naganori Nao, Kazuya Shirato, Proceedings of the National Academy of Sciences Viral EvolutionNovel BetacoronavirusViral DiagnosticsEmerging Infectious DiseasesRespiratory Diseases	2020	1.6K
Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development Masaki Imai, Kiyoko Iwatsuki‐Horimoto, Masato Hatta, Proceedings of the National Academy of Sciences	2020	1.1K
SARS-CoV-2 D614G variant exhibits efficient replication ex vivo and transmission in vivo Yixuan J. Hou, S. Chiba, Peter Halfmann, Science Sars-cov-2 D614g VariantViral ReplicationViral EvolutionSpike Aspartic Acid-614Competitive Fitness	2020	995
The First Identification and Retrospective Study of Severe Fever With Thrombocytopenia Syndrome in Japan Toru Takahashi, Ken Maeda, Tadaki Suzuki, The Journal of Infectious Diseases	2013	909
SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters Peter Halfmann, Shun Iida, Kiyoko Iwatsuki‐Horimoto, Nature	2022	686
Gold Nanoparticles as a Vaccine Platform: Influence of Size and Shape on Immunological Responses <i>in Vitro</i> and <i>in Vivo</i> Kenichi Niikura, Tatsuya Matsunaga, Tadaki Suzuki, ACS Nano NanoparticlesEngineeringImmunologyImmunodominanceVaccine Platform	2013	618
SARS-CoV-2 D614G spike mutation increases entry efficiency with enhanced ACE2-binding affinity Seiya Ozono, Yanzhao Zhang, Hirotaka Ode, Nature Communications	2021	536
Pathology of congenital Zika syndrome in Brazil: a case series Roosecelis B. Martines, Julu Bhatnagar, Ana Maria de Oliveira Ramos, The Lancet FlavivirusCongenital Zika SyndromePediatrics	2016	351
Zika Virus RNA Replication and Persistence in Brain and Placental Tissue Julu Bhatnagar, D. Brett Rabeneck, Roosecelis B. Martines, Emerging infectious diseases Maternal ImmunizationViral ReplicationDevelopmental BiologyReverse Transcription PcrMedicine	2016	211
Potential anti-COVID-19 agents, cepharanthine and nelfinavir, and their usage for combination treatment Hirofumi Ohashi, Koichi Watashi, Wakana Saso, iScience	2021	180

Page 1